ArticleOncoTargets and therapy2015

Hormone receptor status predicts the clinical outcome of human epidermal growth factor 2-positive metastatic breast cancer patients receiving trastuzumab therapy: a multicenter retrospective study.

Yunchao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.